| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.00044 | 1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.00056 | 1 |